{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T17:12:49Z","timestamp":1721927569339},"reference-count":21,"publisher":"Akademiai Kiado Zrt.","issue":"11","license":[{"start":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:00:00Z","timestamp":1615680000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2021,3,14]]},"abstract":"<jats:p><jats:bold>\u00d6sszefoglal\u00f3.<\/jats:bold>\n                    <jats:italic>Bevezet\u00e9s:<\/jats:italic> Az akut pancreatitis az egyik leggyakoribb k\u00f3rh\u00e1zi\n                    felv\u00e9telt ig\u00e9nyl\u0151 gastrointestinalis k\u00f3rk\u00e9p. A korai visszav\u00e9teli ar\u00e1ny egyr\u00e9szt\n                    az ell\u00e1t\u00e1st jellemz\u0151 min\u0151s\u00e9gi mutat\u00f3, m\u00e1sr\u00e9szt az akut pancreatitis 1 \u00e9ves\n                    mortalit\u00e1s\u00e1nak leger\u0151sebb prognosztikai faktora. <jats:italic>C\u00e9lkit\u0171z\u00e9s:<\/jats:italic> A\n                    korai visszav\u00e9tel ar\u00e1ny\u00e1nak, illetve okainak vizsg\u00e1lata klinik\u00e1nkon akut\n                    pancreatitis diagn\u00f3zis\u00e1val kezelt betegek k\u00f6r\u00e9ben. <jats:italic>M\u00f3dszerek:<\/jats:italic>\n                    Retrospekt\u00edv vizsg\u00e1latunkat azon 18 \u00e9v feletti betegek k\u00f6r\u00e9ben v\u00e9gezt\u00fck, akiket\n                    a 2010. janu\u00e1r \u00e9s 2018. december k\u00f6z\u00f6tti id\u0151szakban akut pancreatitis\n                    diagn\u00f3zis\u00e1val kezelt\u00fcnk klinik\u00e1nkon, \u00e9s az els\u0151 emisszi\u00f3t\u00f3l sz\u00e1m\u00edtva 30 napon\n                    bel\u00fcl \u00fajb\u00f3l felv\u00e9telre ker\u00fcltek. A betegek adatait az Akut Pancreatitis\n                    Regiszter \u00e9s a betegnyilv\u00e1ntart\u00f3 rendszer (MedSol ) seg\u00edts\u00e9g\u00e9vel gy\u0171jt\u00f6tt\u00fck\n                    \u00f6ssze. A biliaris, illetve nem biliaris akut pancreatitises eseteket\n                    hasonl\u00edtottuk \u00f6ssze az epidemiol\u00f3giai adatok, a visszav\u00e9tel oka, a visszav\u00e9telig\n                    eltelt \u00e1tlagos id\u0151tartam, \u00e9s a visszav\u00e9tel id\u0151tartama, valamint kimenetele\n                    vonatkoz\u00e1s\u00e1ban. <jats:italic>Eredm\u00e9nyek:<\/jats:italic> Akut pancreatitis diagn\u00f3zis\u00e1val 647\n                    beteg ker\u00fclt felv\u00e9telre. K\u00f6z\u00fcl\u00fck 28 beteg ker\u00fclt \u00fajrafelv\u00e9telre. A leggyakoribb\n                    okok k\u00f6z\u00f6tt 1) peripancreaticus sz\u00f6v\u0151dm\u00e9nyek, 2) ep\u00e9s panaszok \u00e9s 3) az akut\n                    pancreatitis ki\u00fajul\u00e1sa szerepel. A biliaris \u00e9s a nem biliaris pancreatitises\n                    eseteket \u00f6sszehasonl\u00edtva, a visszav\u00e9tel oka ep\u00e9s panasz volt az el\u0151bbi csoport\n                    65,5%-\u00e1ban \u00e9s az ut\u00f3bbi 15%-\u00e1ban. A k\u00f6z\u00e9ps\u00falyos pancreatitises esetek sz\u00e1ma\n                    szignifik\u00e1nsan magasabbnak ad\u00f3dott a nem biliaris csoportban.\n                        <jats:italic>K\u00f6vetkeztet\u00e9s:<\/jats:italic> A k\u00f6z\u00e9ps\u00falyos\/s\u00falyos pancreatitises esetek\n                    ar\u00e1nya magasabb volt a nem biliaris pancreatitises csoportban. Biliaris\n                    pancreatitis eset\u00e9n javasolt index-cholecystectomia v\u00e9gz\u00e9se. Orv Hetil. 2021;\n                    162(11): 413\u2013418.<\/jats:p>\n                <jats:p><jats:bold>Summary.<\/jats:bold>\n                    <jats:italic>Introduction:<\/jats:italic> Acute pancreatitis is the leading cause of\n                    hospitalization among gastrointestinal diseases. The early readmission rate is a\n                    quality marker and the strongest prognostical factor of 1-year mortality of\n                    acute pancreatitis. <jats:italic>Objective:<\/jats:italic> To investigate the rate and\n                    cause of early readmission among patients treated with acute pancreatitis at our\n                    clinic. <jats:italic>Methods<\/jats:italic>: Our retrospective study was conducted among\n                    patients (&gt;18 years) treated with acute pancreatitis between January 2010 and\n                    December 2018 at our clinic, by whom unplanned readmission happened &lt;30 days\n                    from emission. Personal data were collected from the Hungarian Pancreas\n                    Registry. Data of biliary and non-biliary acute pancreatitis cases were compared\n                    concerning epidemiological data, cause of readmission, mean time elapsed until\n                    readmission, its duration and outcome. <jats:italic>Results:<\/jats:italic> 647 patients\n                    were diagnosed with acute pancreatitis. Of them, 28 patients had early\n                    readmission. The most common causes were 1) local pancreatic complications, 2)\n                    biliary and 3) recurrence of acute pancreatitis. By investigating the biliary\n                    and non-biliary pancreatitis cases separately, the cause of readmission was\n                    biliary in 65.5% and 15%, respectively. The number of moderately severe\n                    pancreatitis cases was significantly higher in the non-biliary group.\n                        <jats:italic>Conclusion:<\/jats:italic> The proportion of moderate\/severe diseases was\n                    higher in the non-biliary pancreatitis group. In the case of biliary\n                    pancreatitis, it is suggested to perform index cholecystectomy. Orv Hetil. 2021;\n                    162(11): 413\u2013418.<\/jats:p>","DOI":"10.1556\/650.2021.32045","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T12:09:48Z","timestamp":1617106188000},"page":"413-418","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":1,"title":["Az akut pancreatitist k\u00f6vet\u0151 k\u00f3rh\u00e1zi visszav\u00e9teli ar\u00e1ny mint min\u0151s\u00e9gi mutat\u00f3"],"prefix":"10.1556","volume":"162","author":[{"given":"D\u00f3ra","family":"Ill\u00e9s","sequence":"first","affiliation":[{"name":"1 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati Klinika, Szeged, K\u00e1lv\u00e1ria sgt. 57., 6725"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Czak\u00f3","sequence":"additional","affiliation":[{"name":"1 Szegedi Tudom\u00e1nyegyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar, Belgy\u00f3gy\u00e1szati Klinika, Szeged, K\u00e1lv\u00e1ria sgt. 57., 6725"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1 Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012; 143: 1179-1187.e3.","DOI":"10.1053\/j.gastro.2012.08.002"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/MPA.0000000000001228","article-title":"Temporal trends in incidence and outcomes of acute pancreatitis in hospitalized patients in the United States from 2002 to 2013","volume":"48","author":"2 Brindise","year":"2019","unstructured":"2 Brindise E, Elkhatib I, Kuruvilla A, et al. Temporal trends in incidence and outcomes of acute pancreatitis in hospitalized patients in the United States from 2002 to 2013. Pancreas 2019; 48: 169-175.","journal-title":"Pancreas"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"20150425","DOI":"10.1098\/rstb.2015.0425","article-title":"Ca2+ toxicity and mitochondrial damage in acute pancreatitis: translational overview","volume":"371","author":"Mal\u00e9th J","year":"2016","unstructured":"3 Mal\u00e9th J, Hegyi P. Ca2+ toxicity and mitochondrial damage in acute pancreatitis: translational overview. Philos Trans R Soc Lond B Biol Sci. 2016; 371: 20150425.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"0165309","DOI":"10.1371\/journal.pone.0165309","article-title":"Prospective, multicentre, nationwide clinical data from 600 cases of acute pancreatitis","volume":"11","author":"4 P\u00e1rniczky","year":"2016","unstructured":"4 P\u00e1rniczky A, Kui B, Szentesi A, et al. Prospective, multicentre, nationwide clinical data from 600 cases of acute pancreatitis. PLoS ONE 2016; 11: 0165309.","journal-title":"PLoS ONE"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pan.2015.03.008","article-title":"Predictive factors for and incidence of hospital readmissions of patients with acute and chronic pancreatitis","volume":"15","author":"5 Suchsland","year":"2015","unstructured":"5 Suchsland T, Aghdassi A, K\u00fchn K, et al. Predictive factors for and incidence of hospital readmissions of patients with acute and chronic pancreatitis. Pancreatology 2015; 15: 265-270.","journal-title":"Pancreatology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MPA.0000000000000463","article-title":"Thirty-day readmission predicts 1-year mortality in acute pancreatitis","volume":"45","author":"6 Lee","year":"2016","unstructured":"6 Lee PJ, Bhatt A, Lopez R, et al. Thirty-day readmission predicts 1-year mortality in acute pancreatitis. Pancreas 2016; 45: 561-564.","journal-title":"Pancreas"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.cgh.2014.04.035","article-title":"Risk of and factors associated with readmission after a sentinel attack of acute pancreatitis","volume":"12","author":"7 Vipperla","year":"2014","unstructured":"7 Vipperla K, Papachristou GI, Easler J, et al. Risk of and factors associated with readmission after a sentinel attack of acute pancreatitis. Clin Gastroenterol Hepatol. 2014; 12: 1911-1919.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/MPA.0000000000000078","article-title":"A population-based evaluation of readmissions after first hospitalization for acute pancreatitis","volume":"43","author":"8 Yadav","year":"2014","unstructured":"8 Yadav D, Lee E, Papachristou GI, et al. A population-based evaluation of readmissions after first hospitalization for acute pancreatitis. Pancreas 2014; 43: 630-637.","journal-title":"Pancreas"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/ajg.2012.126","article-title":"Natural history following the first attack of acute pancreatitis","volume":"107","author":"9 Yadav","year":"2012","unstructured":"9 Yadav D, O'Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol. 2012; 107: 1096-1103.","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/ajg.2010.234","article-title":"Early readmission in acute pancreatitis: incidence and risk factors","volume":"105","author":"10 Whitlock","year":"2010","unstructured":"10 Whitlock TL, Repas K, Tignor A, et al. Early readmission in acute pancreatitis: incidence and risk factors. Am J Gastroenterol. 2010; 105: 2492-2497.","journal-title":"Am J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11 Munigala S, Subramaniam D, Subramaniam DP, et al. Predictors for early readmission in acute pancreatitis (AP) in the United States (US). A nationwide population based study. Pancreatology 2017; 17: 534-542.","DOI":"10.1016\/j.pan.2017.05.391"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"12 Banks","year":"2013","unstructured":"12 Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111.","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"13 von Elm","year":"2007","unstructured":"13 von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335: 806-808.","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/MPA.0000000000000952","article-title":"A nationwide analysis","volume":"47","author":"14 Garg","year":"2018","unstructured":"14 Garg SK, Campbell JP, Anugwom C, et al. Incidence and predictors of readmissions in acute pancreatitis. A nationwide analysis. Pancreas 2018; 47: 46-54.","journal-title":"Pancreas"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/AOG.0000000000002740","article-title":"Cumulative financial burden of readmissions for biliary pancreatitis in pregnant women","volume":"132","author":"15 Juo","year":"2018","unstructured":"15 Juo YY, Khrucharoen U, Sanaiha Y, et al. Cumulative financial burden of readmissions for biliary pancreatitis in pregnant women. Obstet Gynecol. 2018; 132: 415-422.","journal-title":"Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/bjs.10222","article-title":"Cost-effectiveness of same-admission versus interval cholecystectomy after mild gallstone pancreatitis in the PONCHO trial","volume":"103","author":"Costa DW","year":"2016","unstructured":"16 Da Costa DW, Dijksman LM, Bouwense SA. Cost-effectiveness of same-admission versus interval cholecystectomy after mild gallstone pancreatitis in the PONCHO trial. Br J Surg. 2016; 103: 1695-1703.","journal-title":"Br J Surg"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1053\/j.gastro.2018.01.032","article-title":"American Gastroenterological Association Institute guideline on initial management of acute pancreatitis","volume":"154","author":"17 Crockett","year":"2018","unstructured":"17 Crockett SD, Wani S, Gardner TB, et al. American Gastroenterological Association Institute guideline on initial management of acute pancreatitis. Gastroenterology 2018; 154: 1096-1101.","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18 Working Group IAP\/APA Acute Pancreatitis Guidelines. IAP\/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13(4 Suppl 2): e1-e15.","DOI":"10.1016\/j.pan.2013.07.063"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"11205","DOI":"10.3748\/wjg.v21.i40.11205","article-title":"Role and timing of endoscopy in acute biliary pancreatitis","volume":"21","author":"Anderloni A","year":"2015","unstructured":"19 Anderloni A, Repici A. Role and timing of endoscopy in acute biliary pancreatitis. World J Gastroenterol. 2015; 21: 11205-11208.","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20 ASGE Standards of Practice Committee, Maple JT, Ben-Menachem T, Anderson MA, et al. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc. 2010; 71: 1-9.","DOI":"10.1016\/j.gie.2009.09.041"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.pan.2019.04.003","article-title":"Antibiotic therapy in acute pancreatitis: from global overuse to evidence based recommendations","volume":"19","author":"21 P\u00e1rniczky","year":"2019","unstructured":"21 P\u00e1rniczky A, Lantos T, T\u00f3th EM, et al., The Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: from global overuse to evidence based recommendations. Pancreatology 2019; 19: 488-499.","journal-title":"Pancreatology"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/11\/article-p413.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/162\/11\/article-p413.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T14:31:07Z","timestamp":1698762667000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/11\/article-p413.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,14]]},"references-count":21,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.1556\/650.2021.32045","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,14]]}}}